CareDx Community
NasdaqGM:CDNA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 7 Analysts
AlloMap Testing And OPTN Project Will Expand Markets Despite Risks
Key Takeaways CareDx's growth fueled by expanded testing services and strategic investments aims to improve margins and revenue cycle management. OPTN contract and international expansion of lab products could diversify and boost long-term revenue streams.
View narrativeUS$32.50
FV
43.4% undervalued intrinsic discount13.83%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Updated narrative